Related Experiment Video

Updated: Aug 6, 2025

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

12.5K

Role of targeting TLR4 signaling axis in liver-related diseases

Ying-Le Tang1, Lin Zhu1, Yan Tao1

  • 1Medical College, Yangzhou University, Yangzhou, China.

Pathology, Research and Practice
|March 14, 2023
PubMed

Insights

Targeting Toll-like receptor 4 (TLR4) signaling in the liver is crucial for treating liver diseases. The TLR4/MyD88/NF-κB pathway often promotes disease progression, suggesting new therapeutic strategies.

Area of Science:

  • Immunology
  • Hepatology
  • Molecular Biology

Background:

  • Toll-like receptor 4 (TLR4) is a key transmembrane protein involved in liver signaling.
  • TLR4-mediated pathways are critical for therapeutic effects targeting the liver.

Purpose of the Study:

  • To comprehensively review the role of endogenous substances targeting the TLR4 signaling axis in various liver diseases.
  • To elucidate the impact of TLR4 pathways on liver disease progression and identify therapeutic implications.

Main Methods:

  • Systematic review of literature on liver diseases including acute liver injury, viral hepatitis, alcoholic and non-alcoholic fatty liver disease, cirrhosis, and liver cancer.
  • Analysis of how endogenous substances modulate the TLR4 pathway in the liver.
  • Evaluation of the role of TLR4 signaling in disease pathogenesis.

Main Results:

  • Activation of the TLR4 signaling axis generally promotes disease progression across major liver disease types.
  • The TLR4/MyD88/NF-κB signaling cascade is identified as the most dominant pathway in liver disease progression.
  • Endogenous substances significantly influence liver function through TLR4-dependent mechanisms.

Conclusions:

  • Targeting the TLR4 signaling axis presents a promising therapeutic avenue for liver diseases.
  • Further research into the comprehensive effects of TLR4-targeting drugs and repurposing existing medications is warranted.
Keywords:
LiverTLR4TLR4 signaling axisTLR4/MyD88/NF-κB

More Related Videos

Induction of an Inflammatory Response in Primary Hepatocyte Cultures from Mice08:32

Induction of an Inflammatory Response in Primary Hepatocyte Cultures from Mice

Published on: March 10, 2017

10.1K
Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology12:36

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

Published on: March 14, 2020

16.1K

Related Concept Videos

Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.3K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.2K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.7K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.1K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
196